The overexpression of VSIG-3, correlated with high tumor malignancy and poor prognosis, has been identified in cancers such as colorectal and hepatocellular carcinoma, often in association with PD-L1 and PD-1 expressions (26). This evidence concerns the gene IGSF11 and cancer.